Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
bioAffinity Technologies, Inc. BIAF

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 14, 2026 8-K 3 signals fired
Core
Clinical Trial Result
Other
Ai Diagnostics Investment Interim Data Positive
Apr 7, 2026 8-K 3 signals fired
Other
Ai Diagnostics Investment Interim Data Positive
Core
Clinical Trial Result
Mar 25, 2026 8-K 0 signals fired
No signals above threshold for this filing.
Mar 17, 2026 8-K 3 signals fired
Other
Ai Diagnostics Investment Safety Differentiated
Core
Clinical Trial Result
Mar 14, 2026 10-K 34 signals fired · top 15
Other
Capital Raising Uncertainty Disclosed Ipo Net Proceeds Disclosure Cash Flow Statement Investing Activities Cybersecurity Risk Management Program Disclosure Nol Carryforward Expiration Disclosure Patent Family Portfolio Disclosure Financing Activities Cash Flow Disclosure Depreciation Expense Composition Disclosure Deferred Tax Asset Valuation Disclosure Emerging Growth Company Status Disclosed Net Loss Reported Board Esg Risk Oversight Disclosed Public Float Disclosure Other Income Expense Disclosure Rsu Psu Vesting Schedule Disclosed
Mar 13, 2026 8-K 2 signals fired
Healthcare
Reimbursement Improving
Other
Ceo Team Pride Statement
Mar 10, 2026 8-K 5 signals fired
Other
Ai Diagnostics Investment Interim Data Positive Kol Endorsement
Core
Clinical Trial Result Indication Expansion
Mar 3, 2026 8-K 2 signals fired
Other
Ai Diagnostics Investment
Core
Lead Asset Progress
Feb 25, 2026 8-K 1 signal fired
Other
Ai Diagnostics Investment
Feb 19, 2026 8-K 3 signals fired
Core
Clinical Trial Result
Other
Interim Data Positive Patient Retention High
Feb 17, 2026 8-K 2 signals fired
Other
Patient Retention High
Core
Clinical Trial Result
Feb 9, 2026 8-K 2 signals fired
Other
Ai Diagnostics Investment Kol Endorsement
Feb 4, 2026 8-K 2 signals fired
Other
Annual Meeting Notice Disclosure Advance Notice Requirement Disclosed
Jan 7, 2026 8-K 5 signals fired
Other
Ceo Team Pride Statement Ai Diagnostics Investment Covenant Compliance Affirmation Interim Data Positive
Core
Clinical Trial Result
Dec 19, 2025 8-K 1 signal fired
Other
Record Date Disclosure
Dec 3, 2025 8-K 2 signals fired
Core
Clinical Trial Result
Other
Interim Data Positive
Nov 14, 2025 10-Q 30 signals fired · top 15
Other
Warrant Valued Black Scholes Nasdaq Minimum Bid Price Delisting Notice Ipo Net Proceeds Disclosure Financing Activities Cash Flow Disclosure Cash Flow Statement Investing Activities Nyse Listing Disclosure Reverse Stock Split Effected Depreciation Expense Composition Disclosure Net Loss Reported Other Income Expense Disclosure Advertising Cost Disclosure Institutional Investment Liquidity Position Snapshot Disclosed Ipo Or Capital Raising Completion
Core
Clinical Trial Result
Nov 14, 2025 8-K 8 signals fired
Other
Net Loss Reported Personnel Cost Decrease Disclosure Executive Transition Gratitude Statement Burn Rate Controlled Administrative Efficiency Liquidity Position Snapshot Disclosed Ceo Team Pride Statement
Healthcare
Reimbursement Improving
Nov 5, 2025 8-K 4 signals fired
Healthcare
Reimbursement Improving Pricing Power Services
Other
Ceo Team Pride Statement Market Share Gaining
Oct 28, 2025 8-K 5 signals fired
Other
Patent Family Portfolio Disclosure Geographic Footprint Disclosure Kol Endorsement Ai Diagnostics Investment
Core
Indication Expansion